Colombo, Eleonora
Doretti, Alberto
Scheveger, Francesco
Maranzano, Alessio
Pata, Giulia
Gagliardi, Delia
Meneri, Megi
Messina, Stefano
Verde, Federico
Morelli, Claudia
Corti, Stefania
Maderna, Luca
Silani, Vincenzo
Ticozzi, Nicola http://orcid.org/0000-0001-5963-7426
Funding for this research was provided by:
Università degli Studi di Milano
Article History
Received: 15 July 2022
Revised: 5 September 2022
Accepted: 26 September 2022
First Online: 2 October 2022
Change Date: 13 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00415-023-11652-y
Declarations
:
: E.Colombo, A.Doretti, F. Scheveger, A. Maranzano, G. Pata, D. Gagliardi, M. Meneri, F. Verde, C. Morelli, S. Corti, L. Maderna report no disclosures. S. Messina received compensation for speaking activities from Eli Lilly and Novartis Pharma AG. V. Silani received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb Srl, and Novartis Pharma AG. He is on the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, and Frontiers in Neurology. N. Ticozzi received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is Associate Editor for Frontiers in Aging Neuroscience.
: This study was approved by the Ethics Committee of IRCCS Istituto Auxologico Italiano (DAMARE 2021_05_18) and conducted according to the principles expressed in the Declaration of Helsinki.